Readers are advised that the press releases and other information posted on this site are current only on their original publication date. Please note that such press releases and other information may now be outdated or rendered inaccurate due to passage of time or subsequent material changes in facts and circumstance.
| Dec. 22, 2021 |
 |
Rated 3.5 stars in The 3rd Nikkei SDGs Management Survey |
| Dec. 22, 2021 |
|
Rated 3 stars in the 5th Nikkei Smart Work Management Survey |
| Dec. 22, 2021 |
 |
Notice Regarding Selection of Prime Market in Tokyo Stock Exchange New Market Segments ( 218KB) |
| Dec. 22, 2021 |
|
Notice of Transition to a Company with Audit ＆ Supervisory Committee (149KB) |
| Nov. 25, 2021 |
|
Financial Results Briefing for 2nd Quarter FY2021 (Abridged version) |
| Nov. 11, 2021 |
 |
Consolidated Financial Results for the Six Months Ended September 30, 2021 |
| Nov. 11, 2021 |
|
Notice Concerning Revisions to Consolidated Financial Results Forecasts for the Six Months Ended September 30, 2021(193KB) |
| Oct. 1, 2021 |
 |
Announcement of Official LinkedIn Account |
| Sep. 10, 2021 |
|
Regarding the Recent Novel Coronavirus Infection at an ESPEC Subsidiary |
| Aug. 31, 2021 |
|
Financial Results Briefing for 1st Quarter FY2021 (Abridged version) |
| Aug. 30, 2021 |
|
Regarding the Recent Novel Coronavirus Infection at ESPEC |
| Aug. 25, 2021 |
|
Regarding the Recent Novel Coronavirus Infection at ESPEC |
| Aug. 20, 2021 |
|
Regarding the Recent Novel Coronavirus Infection at ESPEC and its Subsidiary |
| Aug. 6, 2021 |
|
Consolidated Financial Results for the Three Months Ended June 30, 2021 |
| Aug. 4, 2021 |
|
Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Aug. 4, 2021） |
| Jul. 29, 2021 |
|
Regarding the Recent Novel Coronavirus Infection at ESPEC |
| Jul. 14, 2021 |
|
Corporate Governance Report |
| Jul. 14, 2021 |
|
Notice Concerning Results and Completion of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3) (277KB) |
| Jul. 14, 2021 |
|
Notice Concerning Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3) (400KB) |
| Jun. 25, 2021 |
|
Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Jun. 25, 2021） |
| Jun. 7, 2021 |
|
Financial Results Briefing for FY2020 (Abridged version) |
| May. 26, 2021 |
|
Notice of Revision of Basic Policy on Establishing Internal Control System (298KB) |
| May. 25, 2021 |
|
NOTICE OF THE 68TH ORDINARY GENERAL MEETING OF SHAREHOLDERS |
| May. 24, 2021 |
|
Notice of Differences between Consolidated Financial Forecast Figures and Financial Results for Fiscal 2020 and Resolution of Dividend of Surplus(202KB) |
| May. 24, 2021 |
|
Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 |
| Apr. 28, 2021 |
|
Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Apr. 28, 2021） |
| Apr. 7, 2021 |
|
Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Apr. 7, 2021） |
| Mar. 25, 2021 |
|
Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Mar. 25, 2021） |
| Mar. 4, 2021 |
|
Financial Results Briefing for 3rd Quarter FY2020 (Abridged version) |
| Feb. 18, 2021 |
|
Summary of Financial Results (Consolidated) for the Third Quarter of Fiscal 2020 Ending March 31, 2021 |
| Feb. 18, 2021 |
|
Notice of Revisions of Consolidated Full-Year Financial Forecast and Year-End Dividend Forecast for Fiscal 2020(218KB) |
| Feb. 9, 2021 |
|
Regarding the Recent Novel Coronavirus Infection at ESPEC |
| Feb. 9, 2021 |
|
Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Feb. 9, 2021） |
| Jan. 25, 2021 |
|
Regarding the Recent Novel Coronavirus Infection at ESPEC |
| Jan. 25, 2021 |
|
Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Jan. 25, 2021） |
| Jan. 14, 2021 |
|
Regarding the Recent Novel Coronavirus Infection at ESPEC |
| Jan. 14, 2021 |
|
Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Jan. 14, 2021） |
| Jan. 7, 2021 |
|
Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Jan. 7, 2021） |
